Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 2Phase EARLY_PHASE1 1Phase 3 1Phase 1 1

Status

Recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 120Gynecologic 5Thoracic 1Other 1Endocrine 1

Conditions

Ovarian Neoplasms 2Endometrial Neoplasms 2Granulosa Cell Ovarian Cancer 1Fallopian Tube Neoplasms 1Endometrial Stromal Tumors 1

Interventions

Paclitaxel 233Carboplatin 217Bevacizumab 139Cisplatin 136pembrolizumab 89Gemcitabine 69olaparib 54Docetaxel 47Topotecan 44Radiotherapy 43liposomal doxorubicin 41Taxes 41niraparib 38Cyclophosphamide 36Doxorubicin 30Drug Therapy 29Letrozole 28Nivolumab 27Magnetic Resonance Spectroscopy 25Immunoglobulin G 25Disulfides 24Oxaliplatin 23Albumin-Bound Paclitaxel 23durvalumab 22apatinib 21Etoposide 21Brachytherapy 21lenvatinib 20camrelizumab 20Specimen Handling 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Anastrozole × Gynecologic × Clear all
NCT03624244 2026-02-17

BFR-ESS

Centre Leon Berard

Phase 2 Recruiting
40 enrolled
Gynecologic

Endometrial Stromal Tumors

NCT04469764 2025-07-29

Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer

Jonsson Comprehensive Cancer Center

Phase 2 Recruiting
32 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT03909152 2025-07-28

A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
34 enrolled 9 charts
Gynecologic

Granulosa Cell Ovarian Cancer

NCT04719273 2025-01-08

Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer

Thomas Jefferson University

Phase 2 Active not recruiting
14 enrolled
Gynecologic

Endometrial Neoplasms

NCT00181688 2012-12-05

Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer

Massachusetts General Hospital

Phase 2 Completed
35 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡